"Dose or Strength to be Studied" in ICH M13A [Regulatives / Guidelines]

posted by BEQool  – 2024-10-07 12:33 (274 d 14:45 ago) – Posting: # 24221
Views: 2,163

Hello,

I was wondering the exact same thing but I think that this red text applies just to high-risk products with less than proportional increases in AUC and/or Cmax with increasing dose over the range of strengths proposed (the latter explanation of yours).
Otherwise this would have been written at least in a seperate paragraph as this whole paragraph is talking about less than proportional increases in AUC and/or Cmax with increasing dose.

Regards
BEQool

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,695 registered users;
56 visitors (0 registered, 56 guests [including 10 identified bots]).
Forum time: 03:19 CEST (Europe/Vienna)

If I’d observed all the rules,
I’d never have got anywhere.    Marilyn Monroe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5